Biosimilar therapy for breast cancer, zoledronic acid for bone metastases, the future of Obamacare under Donald Trump, and more
- Author
- American Medical Association
- Published
- Tue 03 Jan 2017
- Episode Link
- http://dx.doi.org/10.1001/jama.2016.12932
Editors’ Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor of JAMA, the Journal of the American Medical Association, for the January 3, 2017 issue
